title: E-cigarettes and cancer patients.
abstract: The increasing popularity and availability of electronic cigarettes (i.e., e-cigarettes) in many countries have promoted debate among health professionals as to what to recommend to their patients who might be struggling to stop smoking or asking about e-cigarettes. In the absence of evidence-based guidelines for using e-cigarettes for smoking cessation, some health professionals have urged caution about recommending them due to the limited evidence of their safety and efficacy, while others have argued that e-cigarettes are obviously a better alternative to continued cigarette smoking and should be encouraged. The leadership of the International Association for the Study of Lung Cancer asked the Tobacco Control and Smoking Cessation Committee to formulate a statement on the use of e-cigarettes by cancer patients to help guide clinical practice. Below is this statement, which we will update periodically as new evidence becomes available.
authors.affiliation: Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC.
authors.forename: K Michael
authors.initials: KM
authors.lastname: Cummings
authors.forename: Carolyn M
authors.initials: CM
authors.lastname: Dresler
authors.forename: John K
authors.initials: JK
authors.lastname: Field
authors.forename: Jesme
authors.initials: J
authors.lastname: Fox
authors.forename: Ellen R
authors.initials: ER
authors.lastname: Gritz
authors.forename: Nasser H
authors.initials: NH
authors.lastname: Hanna
authors.forename: Norihiko
authors.initials: N
authors.lastname: Ikeda
authors.forename: Jacek
authors.initials: J
authors.lastname: Jassem
authors.forename: James L
authors.initials: JL
authors.lastname: Mulshine
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Peters
authors.forename: Nise H
authors.initials: NH
authors.lastname: Yamaguchi
authors.forename: Graham
authors.initials: G
authors.lastname: Warren
authors.forename: Caicun
authors.initials: C
authors.lastname: Zhou
mesh_terms: D066300:Electronic Nicotine Delivery Systems / Q000009:adverse effects*; D006801:Humans; D009369:Neoplasms / Q000209:etiology* / Q000517:prevention & control*; D016540:Smoking Cessation
references.citation: Chest. 2012 Apr;141(4):1110-1113
references.pmid: 22474155
references.citation: PLoS One. 2013 Jun 24;8(6):e66317
references.pmid: 23826093
references.citation: Cancer Causes Control. 2013 Jun;24(6):1223-30
references.pmid: 23553611
references.citation: Drugs. 2013 Apr;73(5):407-26
references.pmid: 23572407
references.citation: J Oncol Pract. 2013 Sep;9(5):258-62
references.pmid: 23943904
references.citation: BMC Public Health. 2010 May 04;10:231
references.pmid: 20441579
references.citation: Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):433-40
references.pmid: 18448268
references.citation: Head Neck Oncol. 2012 Mar 12;4:6
references.pmid: 22409767
references.citation: Am J Prev Med. 2011 Apr;40(4):472-5
references.pmid: 21406283
references.citation: Ann Surg Oncol. 2012 May;19(5):1430-8
references.pmid: 22065194
references.citation: Community Oncol. 2012 Nov 1;9(11):344-352
references.pmid: 23175636
references.citation: Lancet. 2013 Nov 16;382(9905):1629-37
references.pmid: 24029165
references.citation: Nicotine Tob Res. 2004 Dec;6 Suppl 3:S303-10
references.pmid: 15799593
references.citation: Addict Sci Clin Pract. 2013 Mar 05;8:5
references.pmid: 23497603
references.citation: JAMA. 2011 Jun 22;305(24):2548-55
references.pmid: 21693743
references.citation: Addiction. 2013 Jun;108(6):1115-25
references.pmid: 23551515
references.citation: Tob Control. 2014 Mar;23(2):133-9
references.pmid: 23467656
references.citation: Cochrane Database Syst Rev. 2013 May 31;(5):CD009329
references.pmid: 23728690
references.citation: J Clin Oncol. 2012 Jun 10;30(17):2102-11
references.pmid: 22565003
references.citation: Clin Cancer Res. 2013 Apr 15;19(8):1941-8
references.pmid: 23570694
references.citation: Nicotine Tob Res. 2013 Jan;15(1):267-70
references.pmid: 22311962
references.citation: Lancet. 2003 Sep 13;362(9387):847-52
references.pmid: 13678970
references.citation: Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2287-93
references.pmid: 16214906
references.citation: Cancer. 2012 Jun 15;118(12):3153-64
references.pmid: 22271645
references.citation: Patient Educ Couns. 2009 Dec;77(3):398-403
references.pmid: 19846270
references.citation: Radiother Oncol. 2011 Dec;101(3):495-501
references.pmid: 21737169
references.citation: Am Soc Clin Oncol Educ Book. 2013;:359-64
references.pmid: 23714547
references.citation: Cancer. 2014 Feb 15;120(4):562-9
references.pmid: 24496870
references.citation: Tob Control. 2010 Apr;19(2):98-103
references.pmid: 20378585
references.citation: J Natl Cancer Inst. 2011 May 18;103(10):835-8
references.pmid: 21498781
references.citation: Int J Cancer. 2013 Jan 15;132(2):401-10
references.pmid: 22539012
references.citation: N Engl J Med. 2011 Jul 21;365(3):193-5
references.pmid: 21774706
references.citation: BJU Int. 2007 Aug;100(2):281-6; discussion 286
references.pmid: 17419696
references.citation: Am J Prev Med. 2013 Mar;44(3):207-15
references.pmid: 23415116
references.citation: J Natl Cancer Inst. 2007 Mar 7;99(5):365-75
references.pmid: 17341728
references.citation: J Thorac Oncol. 2013 May;8(5):543-8
references.pmid: 23529191
references.citation: J Public Health Policy. 2011 Feb;32(1):16-31
references.pmid: 21150942